FDA — authorised 13 September 2018
- Marketing authorisation holder: ASTRAZENECA AB
- Status: approved
🇺🇸 Lumoxiti in United States
FDA authorised Lumoxiti on 13 September 2018
Marketing authorisation
Lumoxiti in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Lumoxiti approved in United States?
Yes. FDA authorised it on 13 September 2018.
Who is the marketing authorisation holder for Lumoxiti in United States?
ASTRAZENECA AB holds the US marketing authorisation.